1-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)-2-(4-chlorophenoxy)ethan-1-one hydrochloride

Catalog No. :
ACFRNE832
CAS No. :
34161-23-4
Molecular Formula :
C20H22Cl2N2O4
Molecular Weight :
425.31

IUPAC Name:1-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)-2-(4-chlorophenoxy)ethan-1-one hydrochloride

1-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)-2-(4-chlorophenoxy)ethan-1-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)-2-(4-chlorophenoxy)ethan-1-one hydrochloride
IUPAC Name1-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)-2-(4-chlorophenoxy)ethan-1-one hydrochloride
Molecular FormulaC20H22Cl2N2O4
Molecular Weight425.31
SMILESCl.O=C(COC1=CC=C(Cl)C=C1)N1CCN(CC2=CC3=C(C=C2)OCO3)CC1
InChI KeyMVOWQBJZZKOQNU-UHFFFAOYSA-N
SynonymSR-01000806671-4 | Fipexide hydrochloride, analytical standard | SC 998 | Fipexide hydrochloride | UNII-NQ702L425I | SPECTRUM1503222 | BP 662 | HMS1922K07 | J-019471 | Pharmakon1600-01503222 | Water-soluble menthol | Fipexidum hydrochloride | Prestwick_60
CAS No.34161-23-4
PubChem CID161803

Synthetic Route by SureRoute

1. ACFRNE832 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIREQ137 route compound structure diagram
    ACIREQ13713730-98-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRNE832 route product structure diagram
    ACFRNE83234161-23-4
Inquiry

2. ACFRNE832 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFGRI310 route compound structure diagram
    ACFGRI310143999-83-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRNE832 route product structure diagram
    ACFRNE83234161-23-4
Inquiry

Comments (0)